Literature DB >> 21707586

Comment from the Editor-in-Chief on correspondence in this issue on immuno-techniques.

J C McGrath.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21707586      PMCID: PMC3144524          DOI: 10.1111/j.1476-5381.2011.01261.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  8 in total

Review 1.  CB2: a cannabinoid receptor with an identity crisis.

Authors:  Brady K Atwood; Ken Mackie
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  An open letter to our readers on the use of antibodies.

Authors:  Clifford B Saper
Journal:  J Comp Neurol       Date:  2005-12-26       Impact factor: 3.215

3.  How reliable are G-protein-coupled receptor antibodies?

Authors:  Martin C Michel; Thomas Wieland; Gozoh Tsujimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-27       Impact factor: 3.000

4.  Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry.

Authors:  Clifford B Saper; Paul E Sawchenko
Journal:  J Comp Neurol       Date:  2003-10-13       Impact factor: 3.215

5.  Knockout controls and the specificity of cannabinoid CB2 receptor antibodies.

Authors:  John C Ashton
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

6.  'Altered' mesenteric artery SK(Ca) : functional implications?

Authors:  Shaun Sandow; T Hilton Grayson
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

7.  Compromised vascular endothelial cell SK(Ca) activity: a fundamental aspect of hypertension?

Authors:  Christopher J Garland
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

8.  Impairment of endothelial SK(Ca) channels and of downstream hyperpolarizing pathways in mesenteric arteries from spontaneously hypertensive rats.

Authors:  A H Weston; E L Porter; E Harno; G Edwards
Journal:  Br J Pharmacol       Date:  2010-03-08       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.